Despite troublesome safety problems with past entrants into this market, the
veritable epidemic of overweight and obesity continues to make this sector an
extremely attractive target for pharmaceutical developers. This new title
provides a considered view of the market for medical interventions in the
battle against obesity, including U.S. and worldwide market size and growth
forecasts, competitive market share and extensive pharmaceutical pipeline
information.
The report discusses both prescription and OTC drug markets and surgical
interventions. Market size and growth rates are provided through 2010 for:
Prescription Appetite Suppressants
Prescription Lipase Inhibitors
OTC Appetite Suppressants
OTC Fat Substitutes
Surgical Intervetion (dollar- and procedure volumes)
Complete epidemilogical data, detailed descriptions of over 50 compounds in
development for this sector, and profiles of 14 top suppliers are provided as
well.
Table of Contents
Chapter One: Executive Summary
Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors
Chapter Two: Introduction
Overview of Obesity and Weight Management
Definition of Overweight and Obesity
Homeostatic Mechanisms Controlling Energy Balance
Linking Energy Stores in Body Fat with the Hypothalamus
Insulin as the Sensor of Energy Stores in Fat
Integration and Effect on Energy Balance
Regulation of Energy Expenditure and Food Intake
Energy Expenditure
Food Intake
Pathophysiology of Obesity
Obesity Disorder of the Homeostatic Control of Energy Balance
Genetic Factors
Food Intake
Physical Exercise
Causes of Overweight and Obesity
Genetics
Environmental
Socioeconomic
Health Risks
Economic Consequences
Demographics
Obesity Management
Chapter Three: Issues and Trends
Over-the Counter Xenical
Cortisol and Obesity
Weight and Height Trends
Educational Efforts of Physical Activity
Sedentary Behavior in Overweight and Obese Persons
Role of Physical Activity in Body Weight Regulation
Educating Patients About the Benefits of Activity
Cardiovascular and All-Cause Mortality
Cardiovascular Risk Factors
Fat and Muscle During Weight Loss
Physical and Psychologic Well-being
Long-term Weight Maintenance
Fat Gene Mapping Tool
Laser Melts Fat
Ciliary Neurotrophic Factor Update
Drinking and Obesity
Exercise Gene
Trends in Childhood Obesity
Effect of Modernization on Obesity
Insurance Coverage Issues
Medicare
Medicaid
Medicare Coverage of Bariatric Surgery
Selected Weight Loss Programs
Chapter Four: Prescription Pharmaceutical Market
Description of Products
Appetite Suppressants
Sympathomimetic Amine
Monoamine Reuptake Inhibitor
Lipase Inhibitors
Market Size and Growth
World Market
World Market and U.S. Market Analysis
Competitive Analysis
Chapter Five: Over-the-Counter Drugs
Overview
Description of Products
Appetite Suppressants
Noradrenergic Agents
Caffeine-based Agents
Benzocaine-Based Agents
Fat Substitutes
Others
5HTP-Trptophan
Hoodia
Market Size and Growth
World Market
World Market and U.S. Market Analysis
Competitive Analysis
Chapter Six: Surgical Interventions
Overview
Description of Products
Restrictive Surgery
Combined Restrictive and Malabsorptive Surgery
Market Size and Growth
World Market
World Market and U.S. Market Analysis
Procedure Volumes
Chapter Seven: Pharmaceutical Research and Development
Overview
Description of Products
5HT2-C Agonists
APD 356
WAY 629 & WAY 909
5HT-6 Antagonists (BVT.5182)
Adiponectin (ACRP30 Famoxin)
Amylin Analogs (Symlin AC137)
Angiogenesis Inhibitors (TNP-470)
B-3AR Agonists
Botanical P57
Calpain-3
Cannabinoid-1 Receptor antagonists
Acomplia
L-000899055
SLV319
SR 147778
CCK-A Agonists
Cholesterol Metabolites (MSI-1436)
Cholesterol Transport Inhibitors (FM-VP4)
Ciliary Neurotrophic Factor (CNTF) (Axokine)
Extendin-4 (AC3174)
Fatty Acid Synthase Inhibitor (C75)
Fibroblast Growth Factor-1 Inhibitor
FIT Gene and Ion Channel (CSX121, CSX 102 and CXS-829)
医薬品
その他のカテゴリ
FAQ